Delivery Order SPE2DR25D3301-SPE2DR26F19FB
- Not listed
- The Defense Logistics Agency awarded a $16.77K delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of IMFINZI 500 mg/10 mL vials. This competitively awarded, firm fixed-price delivery order is scheduled for completion by December 29, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania location. The award represents a child contract under AmerisourceBergen's larger prime Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $1B...
- The Defense Logistics Agency awarded a $27,986.44 delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of IMFINZI 500 mg/10 ml vials. This is a firm fixed-price, competitively awarded contract with an ultimate completion date of December 9, 2025, to be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a $26,525.70 delivery order to AmerisourceBergen Drug Corp on June 5, 2025, for the supply of IMFINZI 500 mg/10 mL vials. This competitively awarded, firm fixed-price delivery order is scheduled for completion by June 27, 2025, with performance at the contractor's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was utilized for this award. This delivery order represents a task order under AmerisourceBergen's significant...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of IMFINZI (120 mg/2.4 mL vial) with a ceiling value of $2,005.92 and a firm fixed price structure. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The award was made through open competition with no set-aside designation, and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of IMFINZI 500 mg/10 ml vials with a ceiling value of $53,051.40 and a firm fixed price contract type. The order is scheduled for completion by September 29, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania location. This delivery order was competitively awarded with no set-aside designation and represents a child contract under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,268.96 to AmerisourceBergen Drug Corp for IMFINZI 120 MG/2.4 ML vials, a pharmaceutical product for medical supply procurement. This firm fixed-price delivery order, issued on October 31, 2025, is scheduled for completion by November 24, 2025, with performance at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of IMFINZI 500 mg/10 mL vials with a ceiling value of $18,567.99 and a firm fixed price structure. This non-competitive delivery order is set to be completed by June 25, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract carries no set-aside designation, indicating that it was awarded...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of IMFINZI 500 mg/10 mL vials with a ceiling value of $15,915.42. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The order is to be completed by July 11, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This award is a child contract issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $44,726.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp for IMFINZI 500 mg/10 mL vials, with an ultimate completion date of December 30, 2025. The award, issued December 8, 2025, is a non-set-aside competitive procurement fulfilling pharmaceutical supply needs for federal medical programs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for military and veteran healthcare systems, with...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $55,907.80 delivery order on December 9, 2025, for the supply of IMFINZI 500 mg/10 mL vials. This competitive, firm fixed-price contract is scheduled for completion by December 31, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting open competition among qualified vendors. This delivery order represents a task...
- SPE2DR25D3301Indefinite Delivery Contract
- SPE2DR25D3301-SPE2DR26F19FBDelivery Order
The Defense Logistics Agency awarded a $11,181.60 delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of IMFINZI 500 mg/10 mL vials. This is a firm fixed-price, non-set-aside contract with performance through December 31, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under a larger indefinite delivery contract vehicle with DLA. This delivery order falls under AmerisourceBergen's significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen supplies comprehensive medical products including specialty medications, brand-name and generic drugs, vaccines, and medical devices to support military healthcare programs worldwide. The company's contract portfolio demonstrates extensive experience fulfilling federal procurement requirements competitively across multiple therapeutic domains, serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through flexible contract vehicles designed to address global pharmaceutical support needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.2k | 12/8/25 |